FN1 and cancer: Some studies have shown that fibronectin isoform, B-FN is a marker of angiogenesis [122,123] and targeting tumor vasculature using L19 (scFv), a human recombinant specific antibody specific for B-FN, has provided benefit in cancer patients and experimental mouse models [124,125].